Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab.

Abstract

Dermatologic TherapyVolume 32, Issue 3 e12902 Letter to the Editor Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab Astrid C. Chodziuk, Astrid C. Chodziuk Department of Dermatology, Bispebjerg Hospital, Copenhagen, DenmarkSearch for more papers by this authorMisbah N. Ghazanfar, Misbah N. Ghazanfar orcid.org/0000-0003-1475-4121 Department of Dermatology, Bispebjerg Hospital, Copenhagen, DenmarkSearch for more papers by this authorSimon F. Thomsen, Corresponding Author Simon F. Thomsen simonfrancisthomsen@gmail.com orcid.org/0000-0002-4838-300X Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark Correspondence Simon F. Thomsen, Department of Dermatology, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark. Email: simonfrancisthomsen@gmail.comSearch for more papers by this author Astrid C. Chodziuk, Astrid C. Chodziuk Department of Dermatology, Bispebjerg Hospital, Copenhagen, DenmarkSearch for more papers by this authorMisbah N. Ghazanfar, Misbah N. Ghazanfar orcid.org/0000-0003-1475-4121 Department of Dermatology, Bispebjerg Hospital, Copenhagen, DenmarkSearch for more papers by this authorSimon F. Thomsen, Corresponding Author Simon F. Thomsen simonfrancisthomsen@gmail.com orcid.org/0000-0002-4838-300X Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark Correspondence Simon F. Thomsen, Department of Dermatology, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark. Email: simonfrancisthomsen@gmail.comSearch for more papers by this author First published: 09 April 2019 https://doi.org/10.1111/dth.12902Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. Volume32, Issue3May/June 2019e12902 RelatedInformation